Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Make a Passover gift and support Jewish journalism. DONATE NOW
Fast Forward

EPA Denies Trump Advisor Carl Icahn Inappropriately Influenced New Regulations

WASHINGTON (Reuters) – Investor Carl Icahn never wielded excessive influence on U.S. biofuels policy while acting as President Trump’s adviser on regulation, the head of the Environmental Protection Agency said in a letter to a Democratic Sen. Sheldon Whitehouse.

The letter, dated September 11, was a response to repeated requests by Whitehouse and other Democratic lawmakers for information on Icahn’s dual role as an adviser on biofuels regulation and a majority stakeholder in a refining company, CVR Energy, directly affected by those rules.

Icahn ended his adviser role in August after facing criticism that his guidance to Trump represented a conflict of interests as it may have benefited CVR. Icahn has denied the allegations.

EPA Administrator Scott Pruitt said in the letter to Whitehouse, seen by Reuters on Tuesday, that Icahn was “one of many” of Trump’s advisers that he met during his confirmation process, and he “made no assurances with regard to the point of obligation or any other substantive issue.”

The “point of obligation” refers to a requirement under the U.S. Renewable Fuel Standard that refiners blend increasing amounts of biofuels like ethanol into their gasoline every year. Icahn, CVR, and a handful of other refiners wanted to shift that responsibility off refiners in a way that would have saved them hundreds of millions of dollars.

Icahn proposed the reform to the administration in February. The Trump administration has not made a decision on the request, but environmental regulators are preparing to formally reject it, sources have told Reuters.

A spokesman for Whitehouse said the senator was reviewing Pruitt’s response “for accuracy and to determine whether additional steps are warranted.”

This is a moment of great uncertainty. Here’s what you can do about it.

We hope you appreciated this article. Before you go, we’d like to ask you to please support the Forward’s independent Jewish news this Passover. All donations are being matched by the Forward Board - up to $100,000.

This is a moment of great uncertainty for the news media, for the Jewish people, and for our sacred democracy. It is a time of confusion and declining trust in public institutions. An era in which we need humans to report facts, conduct investigations that hold power to account, tell stories that matter and share honest discourse on all that divides us.

With no paywall or subscriptions, the Forward is entirely supported by readers like you. Every dollar you give this Passover is invested in the future of the Forward — and telling the American Jewish story fully and fairly.

The Forward doesn’t rely on funding from institutions like governments or your local Jewish federation. There are thousands of readers like you who give us $18 or $36 or $100 each month or year.

Support our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines.
You must comply with the following:

  • Credit the Forward
  • Retain our pixel
  • Preserve our canonical link in Google search
  • Add a noindex tag in Google search

See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.